Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V-MP in Older Untreated Multiple Myeloma
NCT00388635Phase 2Completed
- Sponsor
- Fundación PETHEMA
- Start
- Apr 2004
- Primary completion
- Jan 2007
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bortezomib in multiple myeloma (MM), sponsored by Fundación PETHEMA. Primary endpoint: Efficacy of V-MP Combination at 1 year. Started Apr 2004; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00388635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00388635.